Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: Involvement of protein kinase C [PDF]
, 2001 Human peritoneal mesothelial cells (HMC) contribute to the activation and control of inflammatory processes in the peritoneum by their potential to produce various inflammatory mediators.
Haslinger, Bettina +4 more
core +1 more source
Patients' experiences of transitioning between different renal replacement therapy modalities : a qualitative study [PDF]
, 2020 BACKGROUND: Different kidney replacement therapy modalities are available to manage end-stage kidney disease, such as home-based dialysis, in-center hemodialysis, and kidney transplantation.
Combes, G +7 more
core +1 more source
Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report
BMC Nephrology, 2018 Background Icodextrin is a starch-derived, water soluble glucose polymer, which is used as an alternative to glucose in order to enhance dialytic fluid removal in peritoneal dialysis patients.
Vassilios Liakopoulos +5 more
doaj +1 more source
Incidence and outcome of encapsulating peritoneal sclerosis [PDF]
, 2016 Background: Studies report variation in the incidence and outcomes of encapsulating peritoneal sclerosis (EPS). This study reports the incidence and outcome of EPS cases in a national cohort of peritoneal dialysis (PD) patients.
Mactier, Robert A. +2 more
core +2 more sources
Peritoneal Dialysis–Associated Peritonitis [PDF]
Clinical Journal of the American Society of Nephrology, 2019 Peritonitis is a common and severe complication in peritoneal dialysis (PD). Detailed recommendations on the prevention and treatment of PD-associated peritonitis have been published by the International Society for Peritoneal Dialysis (ISPD), but there is a substantial variation in clinical practice among dialysis units.
Cheuk-Chun Szeto, Philip Kam-Tao Li
openaire +2 more sources
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy. [PDF]
, 2020 Intraperitoneal vancomycin is the first-line therapy in the management of peritoneal dialysis (PD)-related peritonitis. However, due to the paucity of data, vancomycin dosing for peritonitis in patients on automated peritoneal dialysis (APD) is empiric ...
Kraft, Walter K. +6 more
core +1 more source
HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal [PDF]
, 2018 Peritoneal fibrosis is a pathological alteration of the peritoneal membrane occurring in a variety of conditions including peritoneal dialysis (PD), post-surgery adhesions and peritoneal metastases.
Battistelli, Cecilia +14 more
core +1 more source
Calciphylaxis: A successful outcome whilst on peritoneal dialysis
Bulletin de la Dialyse à Domicile, 2019 Calciphylaxis is a life threatening disease for which patients with chronic kidney disease, particular those on dialysis, are at increased risk. As it is a rare condition, treatment options are limited and duration of treatment is not clear, especially ...
Ana Gaspar +5 more
doaj +1 more source
BMC Nephrology, 2018 Background Urinary mitochondrial DNA (mtDNA) fragment level has been proposed as a biomarker of chronic kidney disease (CKD). In this study, we determine the relation between urinary mtDNA level and rate of renal function deterioration in non-diabetic ...
Zhongping WEI +7 more
doaj +1 more source
Effect of frequent hemodialysis on residual kidney function. [PDF]
, 2013 Frequent hemodialysis can alter volume status, blood pressure, and the concentration of osmotically active solutes, each of which might affect residual kidney function (RKF).
Chertow, Glenn M +11 more
core +1 more source